Epstein-Barr virus: an almost universal infection with an oncogenic side

More than 90% of adults worldwide have encountered Epstein-Barr virus (EBV), usually without realizing it or with mononucleosis-like symptoms during adolescence or early adulthood.

Once inside the body, EBV remains dormant in certain immune cells and causes no problem for the vast majority of people.

Why is it studied so extensively?

In a small minority, this common virus is associated with cancers such as certain lymphomas and nasopharyngeal carcinoma. How can a near-universal virus contribute to cancer in only some people?

The answer lies in a combination of factors

Carrying EBV is not remotely equivalent to developing cancer. Oncovirology studies which genetic, environmental, geographic and co-infection factors allow a dormant virus to participate in tumor development in a small group.

It resembles wildfire conditions: a spark may be widespread, but fire develops only when drought, wind and dry vegetation align.

What this means for you

A past mononucleosis diagnosis or blood test showing prior EBV exposure is not a reason for alarm. Nearly everyone carries it, and almost nobody develops a related complication.

Research aims to identify who truly needs additional attention, not to create fear around an almost universal infection.

EBV belongs to a family of eight human herpesviruses. Meet the others in The herpes family: 8 viruses, and you probably already carry several.

This article provides general educational information and does not replace an individual medical assessment.